Application Software

FOXO Tech

FOXO Tech released FY2026 Q1 earnings on May 15 (EST), actual revenue USD 5.168 M, actual EPS USD -0.0005

FOXO Tech released FY2025 Annual Earnings on April 15 (EST), actual revenue USD 16.37 M, actual EPS USD -0.1323

FOXO Tech released FY2025 Q4 earnings on April 15 (EST) with actual revenue of USD 4.431 M and EPS of USD -0.0186

FOXO Technologies Inc. Unveils Growth Strategy, Expands Subsidiaries and Seeks More Healthcare Acquisitions

FOXO Tech released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 3.548 M, actual EPS USD -0.2937

FOXO Tech released FY2025 9 Months earnings on November 10 (EST), actual revenue USD 11.94 M, actual EPS USD -1.2373

FOXO Tech released FY2025 Semi-Annual Earnings on August 19 (EST), with actual revenue of USD 8.388 M and EPS of USD -0.6813

FOXO Tech released FY2025 Q2 earnings on August 19 (EST), actual revenue USD 5.218 M, actual EPS USD -0.2113

FOXO Technologies Board Approves Actions to Address Small-Cap Issue

FOXO's Myrtle Receives Second Year Funding from Scott County Fund

FOXO Technologies Approves Issuance of Common Stock

FOXO Inc. Announces Launch of New Wound Care Services

FOXO Completes $1.5 Million Equity Financing

FOXO Technologies Board Approves Significant Corporate Actions

FOXO Tech released FY2025 Q1 earnings on May 20 (EST), actual revenue USD 3.17 M, actual EPS USD -0.7322

FOXO Technologies Expands Hospital Wound Care Services

FOXO Technologies Submits 2024 Annual 10-K Report

FOXO Tech released FY2024 Annual Earnings on April 15 (EST), actual revenue USD 4.052 M, actual EPS USD -18.4695

FOXO Tech released FY2024 Q4 earnings on April 15 (EST), actual revenue USD 2.82 M, actual EPS USD -5.2749

FOXO Technologies Inc. Signs Agreement to Acquire Vector Biosource Inc. for $750,000

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

FOXO

Earnings Watch

FOXO Tech | 10-Q: FY2026 Q1 Revenue: USD 5.168 M

FOXOW

SBIO

FOXO Technologies Expands Authorized Class A Share Capacity

Tip Ranks

SPDR S&P Biotech

VG Health

FOXO TECHNOLOGIES INC

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

iShares US Healthcare Providers

SPDR S&P Health

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

Health Care Select Sector SPDR

iShares Global Healthcare

iShares Biotechnology ETF

FOXO Technologies Expands Authorized Class A Share Capacity

FOXO Technologies has signed a Series E Preferred Stock Exchange Agreement with Rennova Health to convert $200,000 in cash advances into equity. The company will issue 8,000 shares of Series E Cumulative Redeemable Secured Preferred Stock at $25.00 per share, fully satisfying and cancelling the prior advances. This private placement agreement was effective on December 31, 2025, allowing FOXO to extinguish debt and convert short-term advances to preferred equity.

TradingView

Proshares Ultra Nasdaq Biotech

Rennova Health, Inc.

FOXO Technologies Signs Series E Preferred Stock Exchange Agreement With Rennova Health

FOXO Technologies has amended the terms of its Series B and C preferred stock, revising the conversion price formula and removing the mandatory conversion provision. Majority stockholder Rennova Health approved an increase in authorized Class A common shares and preferred shares, enhancing FOXO's capital-raising flexibility. Despite these changes, FOXO faces financial challenges, with a low stock score due to net losses, high debt, and negative cash flows. The company is controlled by Rennova Health, holding 98.6% voting rights.

FOXO Technologies Expands Share Authorization and Preferred Terms

FOXO Tech(FOXO.US)

FOXO Tech | 10-Q: FY2026 Q1 Revenue: USD 5.168 M

FOXO Technologies Expands Authorized Class A Share Capacity

FOXO Technologies Signs Series E Preferred Stock Exchange Agreement With Rennova Health

FOXO Technologies Expands Share Authorization and Preferred Terms